These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2198303)

  • 1. Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.
    Robinson DS; Rickels K; Feighner J; Fabre LF; Gammans RE; Shrotriya RC; Alms DR; Andary JJ; Messina ME
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):67S-76S. PubMed ID: 2198303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic anxiolytics and treatment of depression.
    Robinson DS; Alms DR; Shrotriya RC; Messina M; Wickramaratne P
    Psychopathology; 1989; 22 Suppl 1():27-36. PubMed ID: 2657837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone in the management of major depression: a placebo-controlled comparison.
    Fabre LF
    J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies.
    Gammans RE; Stringfellow JC; Hvizdos AJ; Seidehamel RJ; Cohn JB; Wilcox CS; Fabre LF; Pecknold JC; Smith WT; Rickels K
    Neuropsychobiology; 1992; 25(4):193-201. PubMed ID: 1454160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gepirone in the treatment of major depression.
    Jenkins SW; Robinson DS; Fabre LF; Andary JJ; Messina ME; Reich LA
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):77S-85S. PubMed ID: 1973942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone in depressed outpatients: a controlled study.
    Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
    Psychopharmacol Bull; 1990; 26(2):163-7. PubMed ID: 2236452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gepirone as a 5-HT1A agonist in the treatment of major depression.
    Rausch JL; Ruegg R; Moeller FG
    Psychopharmacol Bull; 1990; 26(2):169-71. PubMed ID: 1978370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
    McGrath PJ; Stewart JW; Quitkin FM; Wager S; Jenkins SW; Archibald DG; Stringfellow JC; Robinson DS
    J Clin Psychopharmacol; 1994 Oct; 14(5):347-52. PubMed ID: 7806692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for 5-HT1A agonists in the treatment of depression?
    Blier P; Ward NM
    Biol Psychiatry; 2003 Feb; 53(3):193-203. PubMed ID: 12559651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone therapy in anxious elderly patients: a controlled clinical trial.
    Böhm C; Robinson DS; Gammans RE; Shrotriya RC; Alms DR; Leroy A; Placchi M
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):47S-51S. PubMed ID: 2198301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.
    Docherty JP; Sack DA; Roffman M; Finch M; Komorowski JR
    J Psychiatr Pract; 2005 Sep; 11(5):302-14. PubMed ID: 16184071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.